Followers | 14 |
Posts | 3803 |
Boards Moderated | 1 |
Alias Born | 07/07/2002 |
Friday, November 14, 2014 1:32:15 PM
The literature is not optimistic with regard to combination therapy with LMWH. See link below. What do people here think with regards to m402? Momenta scientists have changed the LMWH characteristics towards lowering anticoagulation activity but it is not clear what other characteristics if any are being optimized.
http://www.medicalnewstoday.com/articles/241707.php
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM